Literature DB >> 22528963

Characterizing POLG ataxia: clinics, electrophysiology and imaging.

Matthis Synofzik1, Karin Srulijes, Jana Godau, Daniela Berg, Ludger Schöls.   

Abstract

Mutations in the mitochondrial DNA polymerase gamma (POLG) cause a highly pleomorphic disease spectrum, and reports about their frequencies in ataxia populations yield equivocal results. This leads to uncertainties about the role of POLG genetics in the workup of patients with unexplained ataxia. A comprehensive characterization of POLG-associated ataxia (POLG-A) will help guide genetic diagnostics and advance our understanding of the disease processes underlying POLG-A. Thirteen patients with POLG-A were assessed by standardized clinical investigation, nerve conduction studies, motor-evoked potentials, magnetic resonance imaging (MRI) and transcranial sonography (TCS). The findings were compared with 13 matched patients with Friedreich's ataxia (FA). In addition to the well-known POLG-associated features of chronic external ophthalmoplegia (100 %), areflexia to the lower extremity (100 %), impaired vibration sense (100 %), bilateral ptosis (69 %) and epilepsy (38 %), also hyperkinetic movement disorders were frequent in POLG-A patients, including chorea (31 %), dystonia (31 %) and myoclonus (23 %). Similar to FA, polyneuropathy was of sensory axonal type (100 %). In contrast to FA, none of the POLG-A patients showed impaired central motor conduction. TCS demonstrated less enlargement of the fourth ventricle and more diffuse cerebellar hyperechogenicity in POLG-A. Corresponding to TCS, MRI revealed no or only mild cerebellar atrophy in most POLG-A patients (85 %). POLG ataxia presents with the clinical characteristics of both afferent and cerebellar ataxia. Cerebellar alterations diffusely involve various parts of the cerebellum, yet cerebellar atrophy is generally mild. POLG-A presents with a high load of distinct non-ataxia features, namely, sensory neuropathy, external ophthalmoplegia, ptosis, epilepsy and/or hyperkinetic movement disorders. Involvement of the corticospinal tract, however, is rare.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528963     DOI: 10.1007/s12311-012-0378-2

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  26 in total

1.  The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.

Authors:  H Jacobi; P Bauer; P Giunti; R Labrum; M G Sweeney; P Charles; A Dürr; C Marelli; C Globas; C Linnemann; L Schöls; M Rakowicz; R Rola; E Zdzienicka; T Schmitz-Hübsch; R Fancellu; C Mariotti; C Tomasello; L Baliko; B Melegh; A Filla; C Rinaldi; B P van de Warrenburg; C C P Verstappen; S Szymanski; J Berciano; J Infante; D Timmann; S Boesch; S Hering; C Depondt; M Pandolfo; J-S Kang; S Ratzka; J Schulz; S Tezenas du Montcel; T Klockgether
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

2.  Common mitochondrial DNA and POLG1 mutations are rare in the Chinese patients with adult-onset ataxia on Taiwan.

Authors:  Yi-Chung Lee; Yi-Chun Lu; Ming-Hon Chang; Bing-Wen Soong
Journal:  J Neurol Sci       Date:  2007-02-14       Impact factor: 3.181

3.  Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene.

Authors:  Rita Horvath; Gavin Hudson; Gianfrancesco Ferrari; Nancy Fütterer; Sofia Ahola; Eleonora Lamantea; Holger Prokisch; Hanns Lochmüller; Robert McFarland; V Ramesh; Thomas Klopstock; Peter Freisinger; Fabrizio Salvi; Johannes A Mayr; Rene Santer; Marketa Tesarova; Jiri Zeman; Bjarne Udd; Robert W Taylor; Douglass Turnbull; Michael Hanna; Doreen Fialho; Anu Suomalainen; Massimo Zeviani; Patrick F Chinnery
Journal:  Brain       Date:  2006-04-18       Impact factor: 13.501

4.  Microglia activation is related to substantia nigra echogenicity.

Authors:  D Berg; J Godau; P Riederer; M Gerlach; T Arzberger
Journal:  J Neural Transm (Vienna)       Date:  2010-11-06       Impact factor: 3.575

5.  Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin.

Authors:  Anna H Hakonen; Silja Heiskanen; Vesa Juvonen; Ilse Lappalainen; Petri T Luoma; Maria Rantamaki; Gert Van Goethem; Ann Lofgren; Peter Hackman; Anders Paetau; Seppo Kaakkola; Kari Majamaa; Teppo Varilo; Bjarne Udd; Helena Kaariainen; Laurence A Bindoff; Anu Suomalainen
Journal:  Am J Hum Genet       Date:  2005-07-27       Impact factor: 11.025

6.  Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes.

Authors:  Charalampos Tzoulis; Gesche Neckelmann; Sverre J Mørk; Bernt E Engelsen; Carlo Viscomi; Gunnar Moen; Lars Ersland; Massimo Zeviani; Laurence A Bindoff
Journal:  Brain       Date:  2010-04-16       Impact factor: 13.501

Review 7.  Clinical features and molecular genetics of autosomal recessive cerebellar ataxias.

Authors:  Brent L Fogel; Susan Perlman
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

8.  Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features.

Authors:  A E Harding
Journal:  Brain       Date:  1981-09       Impact factor: 13.501

9.  The unfolding clinical spectrum of POLG mutations.

Authors:  M J Blok; B J van den Bosch; E Jongen; A Hendrickx; C E de Die-Smulders; J E Hoogendijk; E Brusse; M de Visser; B T Poll-The; J Bierau; I F de Coo; H J Smeets
Journal:  J Med Genet       Date:  2009-07-02       Impact factor: 6.318

Review 10.  Autosomal recessive cerebellar ataxias.

Authors:  Francesc Palau; Carmen Espinós
Journal:  Orphanet J Rare Dis       Date:  2006-11-17       Impact factor: 4.123

View more
  24 in total

Review 1.  Consensus Paper: Neurophysiological Assessments of Ataxias in Daily Practice.

Authors:  W Ilg; M Branscheidt; A Butala; P Celnik; L de Paola; F B Horak; L Schöls; H A G Teive; A P Vogel; D S Zee; D Timmann
Journal:  Cerebellum       Date:  2018-10       Impact factor: 3.847

2.  Moving Beyond Syndromic Classifications in Neurodegenerative Disease: The Example of PLA2G6.

Authors:  Matthis Synofzik; Thomas Gasser
Journal:  Mov Disord Clin Pract       Date:  2016-12-10

3.  Clinical assessment of dysphagia in neurodegeneration (CADN): development, validity and reliability of a bedside tool for dysphagia assessment.

Authors:  Adam P Vogel; Natalie Rommel; Carina Sauer; Marius Horger; Patrick Krumm; Marc Himmelbach; Matthis Synofzik
Journal:  J Neurol       Date:  2017-05-03       Impact factor: 4.849

4.  Palatal Tremor in POLG-Associated Ataxia.

Authors:  Madhu Nagappa; Parayil Sankaran Bindu; Arun B Taly; Kothari Sonam; Chiplunkar Shwetha; Rakesh Kumar; Narayanappa Gayathri; M M Srinivas-Bharath; Hanumanthapura R Arvinda; Sanjib Sinha; Arumugam Paramasivam; Kumarasamy Thangaraj
Journal:  Mov Disord Clin Pract       Date:  2015-06-30

5.  Characteristic brain MRI findings in ataxia-neuropathy spectrum related to POLG mutation.

Authors:  Adriana I Henao; Sonia Pira; Diego A Herrera; Sergio A Vargas; Jorge Montoya; Mauricio Castillo
Journal:  Neuroradiol J       Date:  2016-01-11

Review 6.  Posterior fossa involvement in the diagnosis of adult-onset inherited leukoencephalopathies.

Authors:  Xavier Ayrignac; Clemence Boutiere; Clarisse Carra-Dalliere; Pierre Labauge
Journal:  J Neurol       Date:  2016-04-28       Impact factor: 4.849

7.  Inducible and reversible phenotypes in a novel mouse model of Friedreich's Ataxia.

Authors:  Vijayendran Chandran; Kun Gao; Vivek Swarup; Revital Versano; Hongmei Dong; Maria C Jordan; Daniel H Geschwind
Journal:  Elife       Date:  2017-12-19       Impact factor: 8.140

8.  Mitochondrial POLG related disorder presenting prenatally with fetal cerebellar growth arrest.

Authors:  Michal Inbar-Feigenberg; Susan Blaser; Cynthia Hawkins; Patrick Shannon; Stacy Hewson; David Chitayat
Journal:  Metab Brain Dis       Date:  2018-03-25       Impact factor: 3.584

9.  Friedreich ataxia: dysarthria profile and clinical data.

Authors:  Bettina Brendel; Hermann Ackermann; Daniela Berg; Tobias Lindig; Theresa Schölderle; Ludger Schöls; Matthis Synofzik; Wolfram Ziegler
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

10.  NPC1 is enriched in unexplained early onset ataxia: a targeted high-throughput screening.

Authors:  Matthis Synofzik; Florian Harmuth; Miriam Stampfer; Jennifer Müller Vom Hagen; Ludger Schöls; Peter Bauer
Journal:  J Neurol       Date:  2015-09-04       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.